| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y FAM20C PCDHGA12 PCDH11X MACF1 PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 ATP5F1B | 9.23e-07 | 749 | 164 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.07e-05 | 6 | 164 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.07e-05 | 6 | 164 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 2.96e-05 | 8 | 164 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 4.41e-05 | 9 | 164 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 2.82e-04 | 16 | 164 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 5.60e-04 | 20 | 164 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.90e-04 | 227 | 164 | 8 | GO:0051015 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 9.29e-15 | 187 | 163 | 18 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CLDN14 DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 6.63e-12 | 313 | 163 | 19 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CLDN14 DCHS2 CDH26 ABL1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y LILRB1 ITGB5 PCDHGA12 PCDH11X ATP1B2 PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 1.35e-05 | 1077 | 163 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 2.03e-05 | 21 | 163 | 4 | GO:0000097 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 2.64e-05 | 8 | 163 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | vesicle transport along actin filament | 3.93e-05 | 9 | 163 | 3 | GO:0030050 | |
| GeneOntologyBiologicalProcess | polar body extrusion after meiotic divisions | 5.58e-05 | 10 | 163 | 3 | GO:0040038 | |
| GeneOntologyBiologicalProcess | peptide modification | 5.58e-05 | 10 | 163 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 5.58e-05 | 10 | 163 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 6.12e-05 | 53 | 163 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 7.63e-05 | 11 | 163 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | actin filament-based transport | 7.63e-05 | 11 | 163 | 3 | GO:0099515 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 1.01e-04 | 12 | 163 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | meiotic cytokinesis | 1.31e-04 | 13 | 163 | 3 | GO:0033206 | |
| GeneOntologyBiologicalProcess | cytokinesis | 2.24e-04 | 204 | 163 | 8 | GO:0000910 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 2.52e-04 | 16 | 163 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 2.75e-04 | 40 | 163 | 4 | GO:0000096 | |
| MousePheno | abnormal circulating glutathione level | 7.23e-06 | 5 | 127 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 7.23e-06 | 5 | 127 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 7.23e-06 | 5 | 127 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 7.23e-06 | 5 | 127 | 3 | MP:0012606 | |
| MousePheno | decreased circulating cysteine level | 2.50e-05 | 7 | 127 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 3.97e-05 | 8 | 127 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 3.97e-05 | 8 | 127 | 3 | MP:0004932 | |
| MousePheno | nervous | 5.91e-05 | 9 | 127 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 8.39e-05 | 10 | 127 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 8.39e-05 | 10 | 127 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 8.39e-05 | 10 | 127 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 1.15e-04 | 11 | 127 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 1.15e-04 | 11 | 127 | 3 | MP:0011130 | |
| MousePheno | immotile sperm | 1.93e-04 | 59 | 127 | 5 | MP:0020869 | |
| MousePheno | abnormal cysteine level | 1.96e-04 | 13 | 127 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 1.96e-04 | 13 | 127 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.96e-04 | 13 | 127 | 3 | MP:0012603 | |
| MousePheno | priapism | 2.48e-04 | 14 | 127 | 3 | MP:0003415 | |
| MousePheno | diluted coat color | 2.84e-04 | 64 | 127 | 5 | MP:0000371 | |
| MousePheno | abnormal thyroxine level | 3.28e-04 | 66 | 127 | 5 | MP:0005469 | |
| MousePheno | abnormal copulatory plug deposition | 3.76e-04 | 16 | 127 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 3.76e-04 | 16 | 127 | 3 | MP:0008477 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 3.77e-04 | 68 | 127 | 5 | MP:0003662 | |
| MousePheno | failure of superovulation | 5.41e-04 | 18 | 127 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 5.41e-04 | 18 | 127 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 5.41e-04 | 18 | 127 | 3 | MP:0009093 | |
| MousePheno | abnormal thyroid hormone level | 5.58e-04 | 74 | 127 | 5 | MP:0005468 | |
| MousePheno | increased circulating growth hormone level | 6.38e-04 | 19 | 127 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 6.38e-04 | 19 | 127 | 3 | MP:0031627 | |
| MousePheno | abnormal cerebellar layer morphology | 6.61e-04 | 263 | 127 | 9 | MP:0009956 | |
| MousePheno | decreased long bone epiphyseal plate size | 6.66e-04 | 44 | 127 | 4 | MP:0006396 | |
| MousePheno | absent estrous cycle | 6.66e-04 | 44 | 127 | 4 | MP:0009009 | |
| Domain | Cadherin_CS | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 2.50e-18 | 109 | 162 | 18 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 4.90e-18 | 113 | 162 | 18 | PS00232 |
| Domain | Cadherin | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 4.90e-18 | 113 | 162 | 18 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 5.78e-18 | 114 | 162 | 18 | PS50268 |
| Domain | - | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 5.78e-18 | 114 | 162 | 18 | 2.60.40.60 |
| Domain | CA | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 6.80e-18 | 115 | 162 | 18 | SM00112 |
| Domain | Cadherin-like | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 7.99e-18 | 116 | 162 | 18 | IPR015919 |
| Domain | Cadherin | DCHS2 CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 CDH7 CDH11 | 1.10e-17 | 118 | 162 | 18 | IPR002126 |
| Domain | Cadherin_2 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 | 3.21e-16 | 65 | 162 | 14 | PF08266 |
| Domain | Cadherin_N | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 | 3.21e-16 | 65 | 162 | 14 | IPR013164 |
| Domain | Cadherin_tail | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 5.19e-13 | 37 | 162 | 10 | PF15974 |
| Domain | Cadherin_CBD | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 5.19e-13 | 37 | 162 | 10 | IPR031904 |
| Domain | Cadherin_C | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 2.11e-12 | 42 | 162 | 10 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 2.11e-12 | 42 | 162 | 10 | PF16492 |
| Domain | Protocadherin | 2.71e-08 | 5 | 162 | 4 | PF08374 | |
| Domain | Protocadherin | 2.71e-08 | 5 | 162 | 4 | IPR013585 | |
| Domain | Ski_Sno | 2.19e-05 | 7 | 162 | 3 | PF02437 | |
| Domain | - | 2.19e-05 | 7 | 162 | 3 | 3.10.260.20 | |
| Domain | Transform_Ski | 2.19e-05 | 7 | 162 | 3 | IPR003380 | |
| Domain | DNA-bd_dom_put | 1.00e-04 | 11 | 162 | 3 | IPR009061 | |
| Domain | SH3 | 1.15e-04 | 216 | 162 | 9 | PS50002 | |
| Domain | SH3_domain | 1.32e-04 | 220 | 162 | 9 | IPR001452 | |
| Domain | Tscrpt_reg_SKI_SnoN | 4.44e-04 | 4 | 162 | 2 | IPR023216 | |
| Domain | c-SKI_SMAD_bind | 4.44e-04 | 4 | 162 | 2 | PF08782 | |
| Domain | ACOX | 4.44e-04 | 4 | 162 | 2 | PF01756 | |
| Domain | c-SKI_SMAD_bind | 4.44e-04 | 4 | 162 | 2 | SM01046 | |
| Domain | c-SKI_SMAD4-bd_dom | 4.44e-04 | 4 | 162 | 2 | IPR014890 | |
| Domain | Acyl-CoA_oxidase_C | 4.44e-04 | 4 | 162 | 2 | IPR002655 | |
| Domain | Acyl-CoA_oxidase | 4.44e-04 | 4 | 162 | 2 | IPR012258 | |
| Domain | SH3_9 | 5.85e-04 | 78 | 162 | 5 | PF14604 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | SM00326 | |
| Domain | Myosin_S1_N | 7.35e-04 | 5 | 162 | 2 | IPR008989 | |
| Domain | Dilute_dom | 1.10e-03 | 6 | 162 | 2 | IPR002710 | |
| Domain | DIL | 1.10e-03 | 6 | 162 | 2 | PF01843 | |
| Domain | DILUTE | 1.10e-03 | 6 | 162 | 2 | PS51126 | |
| Domain | DIL | 1.10e-03 | 6 | 162 | 2 | SM01132 | |
| Domain | GGT_peptidase | 1.53e-03 | 7 | 162 | 2 | IPR000101 | |
| Domain | G_glu_transpept | 1.53e-03 | 7 | 162 | 2 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 1.53e-03 | 7 | 162 | 2 | PS00462 | |
| Domain | SH3_1 | 3.10e-03 | 164 | 162 | 6 | PF00018 | |
| Domain | PH_dom-like | RANBP2 ARHGEF28 RAPH1 FRMPD1 TBC1D2B CIT PLCD3 SBF2 PLD1 DCP1A | 4.10e-03 | 426 | 162 | 10 | IPR011993 |
| Domain | Myosin_head_motor_dom | 4.33e-03 | 38 | 162 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.33e-03 | 38 | 162 | 3 | PS51456 | |
| Domain | Myosin_head | 4.33e-03 | 38 | 162 | 3 | PF00063 | |
| Domain | MYSc | 4.33e-03 | 38 | 162 | 3 | SM00242 | |
| Domain | - | 4.66e-03 | 12 | 162 | 2 | 3.10.390.10 | |
| Domain | C8 | 4.66e-03 | 12 | 162 | 2 | PF08742 | |
| Domain | TIL | 4.66e-03 | 12 | 162 | 2 | PF01826 | |
| Domain | SAND_dom-like | 4.66e-03 | 12 | 162 | 2 | IPR010919 | |
| Domain | IQ | 5.41e-03 | 81 | 162 | 4 | SM00015 | |
| Domain | Acyl-CoA_dh_1 | 5.48e-03 | 13 | 162 | 2 | PF00441 | |
| Domain | Unchr_dom_Cys-rich | 5.48e-03 | 13 | 162 | 2 | IPR014853 | |
| Domain | C8 | 5.48e-03 | 13 | 162 | 2 | SM00832 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.35e-03 | 14 | 162 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.35e-03 | 14 | 162 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.35e-03 | 14 | 162 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.35e-03 | 14 | 162 | 2 | PF08393 | |
| Domain | TIL_dom | 6.35e-03 | 14 | 162 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 6.35e-03 | 14 | 162 | 2 | IPR011704 | |
| Domain | MT | 6.35e-03 | 14 | 162 | 2 | PF12777 | |
| Domain | AAA_8 | 6.35e-03 | 14 | 162 | 2 | PF12780 | |
| Domain | AAA_5 | 6.35e-03 | 14 | 162 | 2 | PF07728 | |
| Domain | ANK_REPEAT | 6.65e-03 | 253 | 162 | 7 | PS50088 | |
| Domain | SH3_2 | 6.67e-03 | 86 | 162 | 4 | PF07653 | |
| Domain | SH3_2 | 6.67e-03 | 86 | 162 | 4 | IPR011511 | |
| Domain | ANK_REP_REGION | 6.79e-03 | 254 | 162 | 7 | PS50297 | |
| Domain | - | 7.20e-03 | 391 | 162 | 9 | 2.30.29.30 | |
| Domain | DHC_fam | 7.29e-03 | 15 | 162 | 2 | IPR026983 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 7.29e-03 | 15 | 162 | 2 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 7.29e-03 | 15 | 162 | 2 | IPR009100 | |
| Domain | - | 7.29e-03 | 15 | 162 | 2 | 3.30.70.960 | |
| Domain | Dynein_heavy | 7.29e-03 | 15 | 162 | 2 | PF03028 | |
| Domain | Acyl-CoA_dh_M | 7.29e-03 | 15 | 162 | 2 | PF02770 | |
| Domain | Dynein_heavy_dom | 7.29e-03 | 15 | 162 | 2 | IPR004273 | |
| Domain | IQ_motif_EF-hand-BS | 7.82e-03 | 90 | 162 | 4 | IPR000048 | |
| Domain | Ankyrin_rpt | 7.99e-03 | 262 | 162 | 7 | IPR002110 | |
| Domain | VWF_type-D | 8.28e-03 | 16 | 162 | 2 | IPR001846 | |
| Domain | VWFD | 8.28e-03 | 16 | 162 | 2 | PS51233 | |
| Domain | AT_hook | 8.28e-03 | 16 | 162 | 2 | PF02178 | |
| Domain | VWD | 8.28e-03 | 16 | 162 | 2 | SM00216 | |
| Domain | AcylCo_DH/oxidase_C | 8.28e-03 | 16 | 162 | 2 | IPR009075 | |
| Domain | VWD | 8.28e-03 | 16 | 162 | 2 | PF00094 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.85e-05 | 22 | 104 | 4 | MM15961 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 9.70e-05 | 33 | 104 | 4 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 1.23e-04 | 35 | 104 | 4 | MM15815 | |
| Pubmed | CDH26 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 | 2.18e-20 | 77 | 166 | 15 | 10835267 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 | 6.48e-19 | 74 | 166 | 14 | 10817752 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDH11Y PCDHGA12 PCDH11X PCDH1 PCDH7 PCDHGA8 | 2.09e-18 | 80 | 166 | 14 | 10716726 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 1.07e-12 | 68 | 166 | 10 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 1.94e-12 | 72 | 166 | 10 | 10380929 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JCAD SORBS2 ABL1 ARHGEF28 RAPH1 LARP1 E2F8 KIAA1671 LATS1 ALMS1 FAM13A DOCK7 ANKRD17 MACF1 PAN3 RNF180 PLK1 DNMBP PCDH7 TRAPPC9 CDK3 DCP1A EXOC4 | 2.72e-11 | 861 | 166 | 23 | 36931259 |
| Pubmed | 5.21e-11 | 15 | 166 | 6 | 23515096 | ||
| Pubmed | HAUS6 ARHGEF28 MYO5B ABLIM3 PLCD3 PRR12 ALMS1 TRPM3 SBF2 POP1 MACF1 MINAR1 ZNF518B ZNF606 TRAPPC9 EXOC4 | 2.24e-09 | 493 | 166 | 16 | 15368895 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.73e-09 | 28 | 166 | 6 | 15347688 | |
| Pubmed | FLNB RANBP2 RAPH1 MYO5B PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 DTNB PCDHGA3 PCDHGA2 PCDHGA1 SKIDA1 DNAH2 NUP98 LARP1 NEB LATS1 PCDHGA12 ATXN7 MACF1 DDX21 DNAH6 PCDHGA8 ATP5F1B | 5.71e-09 | 1442 | 166 | 26 | 35575683 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 FLNB CPAMD8 CDH26 DTNB PCDH11Y ENC1 FRMPD1 LARP1 TECTA ITGB5 KIAA1671 KMT2C KIDINS220 FAM13A ATXN7 SBF2 ANKRD17 MACF1 PLA2G6 PAN3 CAMTA1 PCDH1 CLEC16A TRAPPC9 EXOC4 | 1.10e-08 | 1489 | 166 | 26 | 28611215 |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 1.30e-08 | 34 | 166 | 6 | 22884324 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 RANBP2 SORBS2 RAPH1 NUP98 LARP1 YTHDC2 LATS1 GSE1 FAM13A ATXN7 POP1 ANKRD17 EIF3C DDX21 DNMBP PCDH7 DCP1A | 3.76e-08 | 774 | 166 | 18 | 15302935 |
| Pubmed | 6.56e-08 | 44 | 166 | 6 | 19029045 | ||
| Pubmed | MGAT4B ARHGEF28 MYO19 LARP1 YTHDC2 PLCD3 PRR12 GSE1 WASHC5 POP1 DOCK7 MTR ANKRD17 POLDIP2 CLEC16A EXOC4 | 1.04e-07 | 650 | 166 | 16 | 38777146 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 1.07e-07 | 3 | 166 | 3 | 2573352 | |
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 1.61e-07 | 11 | 166 | 4 | 15905963 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 3.20e-07 | 57 | 166 | 6 | 32633719 | |
| Pubmed | ZHX3 ESS2 NUP98 LARP1 PPP1R13B CIT MYO5C KIAA1671 PRR12 KMT2C GSE1 ALMS1 ATXN7 DDX54 MTR ANKRD17 EIF3C POLDIP2 PAN3 PCDH7 TRAPPC9 DCP1A EXOC4 | 3.56e-07 | 1429 | 166 | 23 | 35140242 | |
| Pubmed | RANBP2 HAUS6 PPP1R13B YTHDC2 KIAA1671 KIDINS220 ALMS1 MACF1 DNMBP EXOC4 | 6.09e-07 | 263 | 166 | 10 | 34702444 | |
| Pubmed | 6.27e-07 | 102 | 166 | 7 | 11214970 | ||
| Pubmed | ZHX3 SORBS2 TSPOAP1 FRMPD1 FCHSD2 KIDINS220 GSE1 DOCK7 MACF1 TRAK2 CAMTA1 CLEC16A | 6.77e-07 | 407 | 166 | 12 | 12693553 | |
| Pubmed | FLNB RANBP2 HAUS6 RAPH1 KIAA1671 PRR12 GSE1 ALMS1 DOCK7 ANKRD17 DCP1A EXOC4 | 8.95e-07 | 418 | 166 | 12 | 34709266 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 23615310 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 11003618 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 10392451 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 1.06e-06 | 5 | 166 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 1.06e-06 | 5 | 166 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 1.06e-06 | 5 | 166 | 3 | 11089562 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 1.06e-06 | 5 | 166 | 3 | 12225953 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 7775425 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 9139708 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 1.06e-06 | 5 | 166 | 3 | 9546365 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 1.06e-06 | 5 | 166 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 1.06e-06 | 5 | 166 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 1.06e-06 | 5 | 166 | 3 | 24698228 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 1.06e-06 | 5 | 166 | 3 | 18063838 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 1.06e-06 | 5 | 166 | 3 | 11095909 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 7641802 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 9627710 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 12453183 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 2891746 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 1.06e-06 | 5 | 166 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 1.06e-06 | 5 | 166 | 3 | 8566783 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 30591459 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 1.06e-06 | 5 | 166 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 1.06e-06 | 5 | 166 | 3 | 19760322 | |
| Pubmed | LARGE2 TICRR FLNB EXOSC10 ENC1 FRMPD1 ABLIM3 E2F8 LCLAT1 KMT2C SBF2 POP1 ANKRD17 MACF1 PLD1 PAN3 CAMTA1 DDX21 DCP1A | 1.17e-06 | 1084 | 166 | 19 | 11544199 | |
| Pubmed | 1.98e-06 | 233 | 166 | 9 | 37704626 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 2.11e-06 | 6 | 166 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 2.11e-06 | 6 | 166 | 3 | 8104871 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 11463821 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 25326709 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 12163373 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 22242126 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 17363454 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 8663190 | ||
| Pubmed | HAUS6 EXOSC10 RAPH1 LARP1 PPP1R13B KIAA1671 KMT2C LATS1 ALMS1 DOCK7 PLK1 DCP1A EXOC4 | 2.63e-06 | 549 | 166 | 13 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 RANBP2 HAUS6 EXOSC10 RAPH1 NUP98 LARP1 YTHDC2 KIAA1671 GSE1 ALMS1 ANKRD17 MACF1 EIF3C DDX21 DCP1A ATP5F1B | 2.69e-06 | 934 | 166 | 17 | 33916271 |
| Pubmed | JCAD RANBP2 RAPH1 MYO5B DTNB NUP98 PPP1R13B KIAA1671 GSE1 WASHC5 SBF2 DDX54 GOLIM4 POC5 EIF3C PLK1 PCDH7 DCP1A | 3.06e-06 | 1049 | 166 | 18 | 27880917 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | JCAD RANBP2 HAUS6 RAPH1 RNF135 PPP1R13B KIAA1671 LATS1 ALMS1 WASHC5 POC5 PAN3 PLK1 DNMBP CLEC16A EXOC4 | 3.67e-06 | 853 | 166 | 16 | 28718761 |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 3.69e-06 | 7 | 166 | 3 | 32284594 | |
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 36685533 | ||
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 3.69e-06 | 7 | 166 | 3 | 1968405 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.27e-06 | 256 | 166 | 9 | 33397691 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 ZHX3 DCHS2 TBC1D2B YTHDC2 MEI1 NEB KMT2C DDX54 GALNT5 PLK1 CDH7 | 5.30e-06 | 497 | 166 | 12 | 36774506 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.68e-06 | 208 | 166 | 8 | 33230847 | |
| Pubmed | 7.96e-06 | 209 | 166 | 8 | 36779422 | ||
| Pubmed | 1.01e-05 | 216 | 166 | 8 | 31519766 | ||
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 23863468 | ||
| Pubmed | FLNB RANBP2 EXOSC10 NUP98 LARP1 PRR12 SPATS2L WASHC5 POP1 DDX54 ANKRD17 EIF3C PLD1 DDX21 ATP5F1B | 1.47e-05 | 847 | 166 | 15 | 35850772 | |
| Pubmed | 1.80e-05 | 234 | 166 | 8 | 36243803 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19261908 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25180444 | ||
| Pubmed | Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. | 2.26e-05 | 2 | 166 | 2 | 11003707 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25687328 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24086300 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25280803 | ||
| Pubmed | Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala. | 2.26e-05 | 2 | 166 | 2 | 22592879 | |
| Pubmed | MLL5 maintains spindle bipolarity by preventing aberrant cytosolic aggregation of PLK1. | 2.26e-05 | 2 | 166 | 2 | 27002166 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 14727141 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21276771 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16874762 | ||
| Pubmed | PCDH11 is X/Y homologous in Homo sapiens but not in Gorilla gorilla and Pan troglodytes. | 2.26e-05 | 2 | 166 | 2 | 16825765 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23600975 | ||
| Pubmed | A comparative analysis of the pig, mouse, and human PCDHX genes. | 2.26e-05 | 2 | 166 | 2 | 15112107 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22744706 | ||
| Pubmed | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. | 2.26e-05 | 2 | 166 | 2 | 21423673 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 37904480 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19039035 | ||
| Interaction | PCDHGA4 interactions | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA12 PCDH1 PCDHGA8 | 5.53e-12 | 34 | 164 | 9 | int:PCDHGA4 |
| Interaction | PCDHGA7 interactions | 4.13e-08 | 25 | 164 | 6 | int:PCDHGA7 | |
| Interaction | PCDHGA12 interactions | 8.55e-07 | 10 | 164 | 4 | int:PCDHGA12 | |
| Interaction | PCDHGA8 interactions | 5.23e-06 | 5 | 164 | 3 | int:PCDHGA8 | |
| Interaction | PCDHGA9 interactions | 6.63e-06 | 33 | 164 | 5 | int:PCDHGA9 | |
| Interaction | PCDHGA5 interactions | 1.23e-05 | 63 | 164 | 6 | int:PCDHGA5 | |
| Interaction | SFN interactions | JCAD SORBS2 ABL1 ARHGEF28 LARP1 NEB KIAA1671 LATS1 ALMS1 FAM13A DOCK7 ANKRD17 MACF1 EIF3C PAN3 DNMBP PCDH7 DCP1A | 1.43e-05 | 692 | 164 | 18 | int:SFN |
| Interaction | H2BC5 interactions | TSPOAP1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 EIF3C PCDHGA8 | 1.78e-05 | 331 | 164 | 12 | int:H2BC5 |
| Interaction | CBX6 interactions | PCDHGA9 PCDHGA6 PCDHGA5 LARP1 YTHDC2 CPM SPATS2L SCMH1 DDX54 ANKRD17 DDX21 | 2.12e-05 | 283 | 164 | 11 | int:CBX6 |
| Interaction | ENTR1 interactions | HAUS6 TBC1D2B PPP1R13B KIAA1671 LATS1 ALMS1 WASHC5 PLK1 CLEC16A | 2.41e-05 | 188 | 164 | 9 | int:ENTR1 |
| Interaction | RAET1E interactions | 2.76e-05 | 22 | 164 | 4 | int:RAET1E | |
| Interaction | SULT1C4 interactions | 3.28e-05 | 110 | 164 | 7 | int:SULT1C4 | |
| Interaction | DHFR interactions | 3.52e-05 | 152 | 164 | 8 | int:DHFR | |
| Interaction | PCDHGA6 interactions | 3.96e-05 | 24 | 164 | 4 | int:PCDHGA6 | |
| Interaction | WWTR1 interactions | HAUS6 EXOSC10 RAPH1 LARP1 PPP1R13B APEX1 RUNX2 KIAA1671 LATS1 ALMS1 DOCK7 PLK1 EXOC4 | 4.34e-05 | 422 | 164 | 13 | int:WWTR1 |
| Interaction | RNF43 interactions | RANBP2 HAUS6 NUP98 LARP1 PPP1R13B YTHDC2 KIAA1671 KIDINS220 ALMS1 MTR MACF1 DNMBP EXOC4 | 4.90e-05 | 427 | 164 | 13 | int:RNF43 |
| Interaction | RYK interactions | PCDHGA7 PCDHGA6 PCDHGA5 RYK KIDINS220 PCDHGA12 PLD1 PCDH1 PCDH7 | 6.17e-05 | 212 | 164 | 9 | int:RYK |
| Interaction | CNTROB interactions | 6.58e-05 | 166 | 164 | 8 | int:CNTROB | |
| Interaction | SYNE3 interactions | JCAD RANBP2 SORBS2 NUP98 PPP1R13B KIAA1671 LATS1 KIDINS220 GSE1 ALMS1 MACF1 PAN3 PLK1 | 7.28e-05 | 444 | 164 | 13 | int:SYNE3 |
| Interaction | MAPRE1 interactions | FLNB RANBP2 SORBS2 RAPH1 NUP98 LARP1 PPP1R13B CPM ALMS1 CKAP2L MACF1 PLK1 DDX21 DNMBP | 8.28e-05 | 514 | 164 | 14 | int:MAPRE1 |
| Interaction | YWHAH interactions | JCAD TICRR SORBS2 ABL1 ARHGEF28 LARP1 E2F8 KIAA1671 LATS1 ALMS1 FAM13A DOCK7 ANKRD17 MACF1 PAN3 PLK1 DNMBP CLEC16A TRAPPC9 CDK3 DCP1A EXOC4 | 8.95e-05 | 1102 | 164 | 22 | int:YWHAH |
| Interaction | AFDN interactions | JCAD DCAF15 SORBS2 PPP1R13B ABLIM3 RYK KIAA1671 KIDINS220 MACF1 DNMBP PCDH7 | 9.24e-05 | 333 | 164 | 11 | int:AFDN |
| Interaction | CEP63 interactions | 1.11e-04 | 179 | 164 | 8 | int:CEP63 | |
| Interaction | PCDHA9 interactions | 1.27e-04 | 32 | 164 | 4 | int:PCDHA9 | |
| Interaction | ANAPC2 interactions | 1.31e-04 | 234 | 164 | 9 | int:ANAPC2 | |
| Interaction | EZR interactions | MPP3 HAUS6 RAPH1 PALMD CIT MYO5C KIAA1671 SLC9A1 KIDINS220 WASHC5 DOCK7 MACF1 PCDH7 TRAPPC9 | 1.78e-04 | 553 | 164 | 14 | int:EZR |
| Interaction | SYNPO interactions | 1.81e-04 | 192 | 164 | 8 | int:SYNPO | |
| Interaction | GGT2P interactions | 1.96e-04 | 3 | 164 | 2 | int:GGT2P | |
| Interaction | YWHAG interactions | JCAD TICRR SORBS2 ABL1 ARHGEF28 RAPH1 LARP1 E2F8 KIAA1671 LATS1 ALMS1 FAM13A DOCK7 ANKRD17 MACF1 PAN3 PLK1 DNMBP PCDH7 TRAPPC9 DCP1A ATP5F1B EXOC4 | 2.00e-04 | 1248 | 164 | 23 | int:YWHAG |
| Interaction | ABCG2 interactions | 2.03e-04 | 36 | 164 | 4 | int:ABCG2 | |
| Interaction | BICD1 interactions | 2.15e-04 | 250 | 164 | 9 | int:BICD1 | |
| Interaction | CAPZA2 interactions | FLNB SORBS2 MYO5B MYO19 CPM CIT MYO5C KIAA1671 WASHC5 DOCK7 MACF1 PCDH7 | 2.16e-04 | 430 | 164 | 12 | int:CAPZA2 |
| Cytoband | 5q31 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 1.56e-11 | 115 | 166 | 10 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 PCDHGA8 | 1.39e-08 | 298 | 166 | 11 | chr5q31 |
| Cytoband | 19q13.4 | 2.01e-04 | 79 | 166 | 4 | 19q13.4 | |
| Cytoband | 5q22.2 | 4.60e-04 | 9 | 166 | 2 | 5q22.2 | |
| Cytoband | 2p24 | 8.38e-04 | 12 | 166 | 2 | 2p24 | |
| GeneFamily | Clustered protocadherins | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8 | 4.81e-12 | 64 | 109 | 10 | 20 |
| GeneFamily | Non-clustered protocadherins | 5.96e-07 | 12 | 109 | 4 | 21 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 5.83e-05 | 13 | 109 | 3 | 564 | |
| GeneFamily | Myosins, class V | 1.08e-04 | 3 | 109 | 2 | 1100 | |
| GeneFamily | SKI transcriptional corepressors | 2.14e-04 | 4 | 109 | 2 | 748 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 3.56e-04 | 5 | 109 | 2 | 1182 | |
| GeneFamily | Phospholipases | 2.06e-03 | 42 | 109 | 3 | 467 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.69e-03 | 13 | 109 | 2 | 1186 | |
| GeneFamily | Dyneins, axonemal | 4.62e-03 | 17 | 109 | 2 | 536 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 5.64e-06 | 108 | 165 | 7 | MM1334 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | THSD4 TICRR HAUS6 SORBS2 ENC1 SKIDA1 LARP1 APEX1 SLCO3A1 CPM E2F8 LCLAT1 MEOX1 FAM20C ALMS1 ZNF518B CAMTA1 CDH11 | 1.47e-05 | 749 | 160 | 18 | gudmap_kidney_P3_CapMes_Crym_1000 |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MPP3 SORBS2 ARHGEF28 MYO5B RGL3 MYO5C TC2N FAM13A TRPM3 GALNT5 | 2.17e-09 | 186 | 166 | 10 | 4e94158db52df41d71e67b02b9895a358eebee0f |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SORBS2 ARHGEF28 MYO5B RGL3 PPP1R13B CPM E2F8 MYO5C TC2N ACOXL | 2.29e-09 | 187 | 166 | 10 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | THSD4 NUP98 KMT2C FCHSD2 SBF2 ANKRD17 PAN3 HS3ST4 TRAPPC9 EXOC4 | 3.11e-09 | 193 | 166 | 10 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CPAMD8 MYO5B DTNB RGL3 PPP1R13B CPM MYO5C TC2N GOLGA8A ACOXL | 3.11e-09 | 193 | 166 | 10 | a0ca3231992f14abcf1a6129573bace320e89d2a |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.26e-09 | 194 | 166 | 10 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | THSD4 ARHGEF28 DTNB KMT2C FCHSD2 SCMH1 SBF2 PAN3 TRAPPC9 EXOC4 | 4.17e-09 | 199 | 166 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | THSD4 FLNB SORBS2 ARHGEF28 MYO5B DTNB MUC16 PPP1R13B MYO5C KIAA1671 | 4.38e-09 | 200 | 166 | 10 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.52e-08 | 186 | 166 | 9 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.22e-08 | 190 | 166 | 9 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.22e-08 | 190 | 166 | 9 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.62e-08 | 192 | 166 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-08 | 192 | 166 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.28e-08 | 195 | 166 | 9 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.76e-08 | 197 | 166 | 9 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 200 | 166 | 9 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-07 | 177 | 166 | 8 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-07 | 179 | 166 | 8 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-07 | 180 | 166 | 8 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.12e-07 | 181 | 166 | 8 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.12e-07 | 181 | 166 | 8 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.48e-07 | 183 | 166 | 8 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.67e-07 | 184 | 166 | 8 | 629cfed10e1112cf30f6a828ce9efbbc6b207789 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-07 | 185 | 166 | 8 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.07e-07 | 186 | 166 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.19e-07 | 191 | 166 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.24e-07 | 195 | 166 | 8 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.24e-07 | 195 | 166 | 8 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.53e-07 | 196 | 166 | 8 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.82e-07 | 197 | 166 | 8 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.29e-06 | 168 | 166 | 7 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 171 | 166 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 171 | 166 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-06 | 174 | 166 | 7 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-06 | 174 | 166 | 7 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-06 | 177 | 166 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-06 | 177 | 166 | 7 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.00e-06 | 179 | 166 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 179 | 166 | 7 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-06 | 184 | 166 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.99e-06 | 184 | 166 | 7 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.20e-06 | 185 | 166 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-06 | 185 | 166 | 7 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 187 | 166 | 7 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 187 | 166 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.65e-06 | 187 | 166 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-06 | 188 | 166 | 7 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.89e-06 | 188 | 166 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-06 | 188 | 166 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.38e-06 | 190 | 166 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.64e-06 | 191 | 166 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.64e-06 | 191 | 166 | 7 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 7.64e-06 | 191 | 166 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 192 | 166 | 7 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 192 | 166 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 192 | 166 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 192 | 166 | 7 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.18e-06 | 193 | 166 | 7 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.18e-06 | 193 | 166 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 194 | 166 | 7 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 194 | 166 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 194 | 166 | 7 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.04e-06 | 196 | 166 | 7 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.35e-06 | 197 | 166 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.35e-06 | 197 | 166 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.35e-06 | 197 | 166 | 7 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 9.35e-06 | 197 | 166 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.66e-06 | 198 | 166 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.66e-06 | 198 | 166 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.66e-06 | 198 | 166 | 7 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.66e-06 | 198 | 166 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.66e-06 | 198 | 166 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.66e-06 | 198 | 166 | 7 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 9.98e-06 | 199 | 166 | 7 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 9.98e-06 | 199 | 166 | 7 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.98e-06 | 199 | 166 | 7 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-05 | 200 | 166 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 1.03e-05 | 200 | 166 | 7 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 1.03e-05 | 200 | 166 | 7 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 200 | 166 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 134 | 166 | 6 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 149 | 166 | 6 | 2624ad3926efc9f0f169daae263cef16861f132b | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.20e-05 | 90 | 166 | 5 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.20e-05 | 90 | 166 | 5 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.95e-05 | 159 | 166 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.28e-05 | 162 | 166 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 164 | 166 | 6 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-05 | 164 | 166 | 6 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 3.63e-05 | 165 | 166 | 6 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.75e-05 | 166 | 166 | 6 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.75e-05 | 166 | 166 | 6 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-05 | 168 | 166 | 6 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-05 | 170 | 166 | 6 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.43e-05 | 171 | 166 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.58e-05 | 172 | 166 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 172 | 166 | 6 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 4.73e-05 | 173 | 166 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| Drug | CID9959010 | 3.54e-07 | 39 | 165 | 6 | CID009959010 | |
| Drug | montmorillonite | 4.14e-07 | 40 | 165 | 6 | CID000517273 | |
| Drug | AC1L1UVI | 2.86e-06 | 55 | 165 | 6 | CID000061263 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A | 7.51e-06 | 182 | 165 | 9 | 1160_UP | |
| Disease | childhood trauma measurement, alcohol consumption measurement | CLDN14 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 SIM2 PCDHGA12 PCDHGA8 | 4.80e-15 | 71 | 162 | 12 | EFO_0007878, EFO_0007979 |
| Disease | mental development measurement | PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA8 | 6.86e-15 | 25 | 162 | 9 | EFO_0008230 |
| Disease | Sarcosine measurement | 3.00e-11 | 23 | 162 | 7 | EFO_0021668 | |
| Disease | mean platelet volume | MPP3 JCAD HAUS6 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 XNDC1N GSE1 FAM13A TRPM3 PCDHGA12 DOCK7 CKAP2L CAMTA1 PCDHGA8 ATP5F1B | 2.10e-07 | 1020 | 162 | 21 | EFO_0004584 |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 5.59e-06 | 7 | 162 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 8.92e-06 | 8 | 162 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | visfatin measurement | 1.04e-04 | 17 | 162 | 3 | EFO_0801230 | |
| Disease | FEV/FEC ratio | THSD4 JCAD DCHS2 PDE3A ARHGEF28 PCDHGA5 PCDHGA1 SKIDA1 RUNX2 MEI1 NEB BTBD16 PRR12 SPATS2L FAM13A FCGR2A SBF2 CLEC16A | 1.49e-04 | 1228 | 162 | 18 | EFO_0004713 |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 3.42e-04 | 25 | 162 | 3 | EFO_0004612, EFO_0007800 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 4.17e-04 | 321 | 162 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | spina bifida (is_implicated_in) | 4.43e-04 | 6 | 162 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | lymphocyte count | JCAD FLNB ABL1 RAPH1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 ENC1 ALMS1 PCDHGA12 PLA2G6 CLEC16A PCDHGA8 ACOXL | 4.49e-04 | 1464 | 162 | 19 | EFO_0004587 |
| Disease | serum gamma-glutamyl transferase measurement | THSD4 JCAD SORBS2 A1CF TMPRSS11E RNF135 CPM CIT GGT1 GSE1 FAM227A DNMBP ACOXL EXOC4 | 5.42e-04 | 914 | 162 | 14 | EFO_0004532 |
| Disease | mitochondrial heteroplasmy measurement | 5.73e-04 | 69 | 162 | 4 | EFO_0600008 | |
| Disease | pulse pressure measurement | THSD4 JCAD FLNB HAUS6 PDE3A RAPH1 RGL3 MEI1 ITGB5 RYK PLCD3 FAM13A TRPM3 ATXN7 SBF2 POC5 CLEC16A TRAPPC9 | 6.66e-04 | 1392 | 162 | 18 | EFO_0005763 |
| Disease | asthma, seasonal allergic rhinitis | 7.17e-04 | 32 | 162 | 3 | EFO_0003956, MONDO_0004979 | |
| Disease | brain measurement, neuroimaging measurement | THSD4 ZHX3 DCHS2 RNF135 SKIDA1 RUNX2 LATS1 ATXN7 MACF1 EXOC4 | 9.65e-04 | 550 | 162 | 10 | EFO_0004346, EFO_0004464 |
| Disease | post operative nausea and vomiting | 1.05e-03 | 9 | 162 | 2 | EFO_0004888 | |
| Disease | waist-hip ratio | THSD4 JCAD ZHX3 CPAMD8 SLCO3A1 YTHDC2 ABLIM3 KIDINS220 GSE1 FAM13A SBF2 POC5 PLD1 ATP1B2 CLEC16A ACOXL | 1.21e-03 | 1226 | 162 | 16 | EFO_0004343 |
| Disease | Cleft palate, isolated | 1.59e-03 | 42 | 162 | 3 | C1837218 | |
| Disease | cysteine-glutathione disulfide measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0021001 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.84e-03 | 315 | 162 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.91e-03 | 12 | 162 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0800413 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.28e-03 | 166 | 162 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.36e-03 | 101 | 162 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.39e-03 | 330 | 162 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | receptive language perception, parental genotype effect measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | alopecia areata | 2.64e-03 | 50 | 162 | 3 | EFO_0004192 | |
| Disease | unipolar depression | JCAD ZHX3 MGAT4B YTHDC2 CPM MEI1 KIAA1671 TRPM3 PLD1 CAMTA1 DDX21 DNAH6 PCDH1 TRAPPC9 ACOXL | 2.73e-03 | 1206 | 162 | 15 | EFO_0003761 |
| Disease | N-acetylmethionine measurement | 3.00e-03 | 15 | 162 | 2 | EFO_0021427 | |
| Disease | hepcidin:transferrin saturation ratio | 3.00e-03 | 15 | 162 | 2 | EFO_0007902 | |
| Disease | platelet component distribution width | MPP3 JCAD HEMGN GSE1 TRPM3 DOCK7 MACF1 PLA2G6 CAMTA1 ACOXL ATP5F1B | 3.13e-03 | 755 | 162 | 11 | EFO_0007984 |
| Disease | skin aging measurement | 3.31e-03 | 181 | 162 | 5 | EFO_0008006 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.39e-03 | 447 | 162 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | focal segmental glomerulosclerosis | 3.42e-03 | 16 | 162 | 2 | EFO_0004236 | |
| Disease | interleukin-6 measurement | 3.43e-03 | 112 | 162 | 4 | EFO_0004810 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.46e-03 | 55 | 162 | 3 | EFO_0022234 | |
| Disease | 1-Methylhistidine measurement | 3.86e-03 | 17 | 162 | 2 | EFO_0021543 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 4.22e-03 | 59 | 162 | 3 | EFO_0022248 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.31e-03 | 276 | 162 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | testosterone measurement | ZHX3 DCHS2 HAUS6 TMPRSS11E DNAH2 RYK LCLAT1 SKOR2 SBF2 MACF1 MINAR1 HS3ST4 ATP1B2 DNMBP ZNF654 | 4.57e-03 | 1275 | 162 | 15 | EFO_0004908 |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | emphysema pattern measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0005850 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PAQSRKFYHPQSSSA | 336 | F5H4B4 | |
| DVRSSTPTSYQAPKH | 416 | O94929 | |
| ETIRHENKPYVPSSA | 1661 | A6H8Y1 | |
| EYKARALPTLPSSQH | 951 | Q9Y6Y1 | |
| NTKAIRTTAHYDPAT | 166 | O15254 | |
| QTYAAIPSLHFPATK | 351 | Q9NQ94 | |
| QRIKHTDLESPSAVY | 421 | Q32M84 | |
| VHYNIPELQSSSRAP | 1061 | Q14687 | |
| LIPTHTQPSYRFKAN | 81 | P12318 | |
| EKPSIFYQQSLPSSH | 1291 | Q8TCU4 | |
| PTITSPSYSQHRAKS | 1516 | Q8TCU4 | |
| PSHSADPYVAKLANI | 251 | A7E2U8 | |
| SFLKPYNPRRSHSDA | 1341 | Q6XZF7 | |
| AVPLADSFRHLYPNT | 246 | P27695 | |
| KEHRNVSDYTPLSLA | 1176 | O75179 | |
| PASITQSNEKHAPTY | 296 | Q9NPI6 | |
| QSNEKHAPTYTIPLS | 301 | Q9NPI6 | |
| PPTYNEHITKRVASS | 1926 | O14578 | |
| TPIVHSPLRYQSDAD | 676 | Q96KQ4 | |
| APTAVHPVRDYAAQT | 36 | P06576 | |
| VAPDGQYHSPIRNKS | 211 | Q9NUZ1 | |
| ADSEIKHSTPSPTRY | 771 | P49792 | |
| NRIAKPSHASYSLDD | 141 | Q70E73 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5G6 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5H1 | |
| VPARSPSETLAYQHL | 1611 | O95153 | |
| PAVRVSFYHADQLKP | 151 | Q8N3Y3 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5G8 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5G5 | |
| TDSRKSHLIFPQPNY | 761 | O60330 | |
| HQKPDFLATATAAYP | 46 | P50221 | |
| KLNPSVIHQDATYPT | 1581 | Q8N1W1 | |
| PVLSKEQPAFQYSSH | 306 | Q9Y2S7 | |
| LPSASKEPDNHVYTR | 26 | A6NGU5 | |
| QEIHSATKPSTVPYK | 9011 | Q8WXI7 | |
| ASERNSKSPTEYHEP | 246 | Q9NP74 | |
| AAKYPRTIHPESSTS | 536 | Q8NA72 | |
| VPRQHYQKETESAPG | 506 | Q6PKG0 | |
| TNPAAQKALTTPTHY | 536 | P52948 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5G7 | |
| SYTRLSKDPPELHAA | 1741 | Q9ULH0 | |
| HVRIPNSYEVSSAPD | 4106 | Q8NEZ4 | |
| EYANPALPSVLAKHS | 266 | Q8NCT3 | |
| SPTASALRKPQLSHY | 981 | Q9BY89 | |
| HVNPPAEVSTSLKTY | 396 | Q9UQ53 | |
| AKPAPRALSTAAVHY | 41 | P13196 | |
| AAVHYQQIKETPPAS | 51 | P13196 | |
| QQSASYIPKITHPTD | 1021 | O95835 | |
| PSYQKRSLLHLPDSS | 1696 | Q86WG5 | |
| STTPHYIRCIKPNSQ | 611 | Q96H55 | |
| VSDHTPKYQDRLATP | 66 | P14415 | |
| YQFNSRKPITPEHST | 291 | Q53G44 | |
| KSYNSSPVTAQEPAH | 451 | Q9P266 | |
| DITVAYPHNIPQSEK | 256 | Q6UWP7 | |
| AHIYSALDPTARKIN | 366 | Q8TDD1 | |
| ARHSARPYTAPEVNK | 566 | Q53TS8 | |
| HNANDTFTVKYVPPA | 801 | O75369 | |
| TYDIHDPKSSARPAD | 151 | Q5SWX8 | |
| SHIPEATPKYSETNA | 461 | Q7Z5P9 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5G4 | |
| DSRKSHLIFPQPNYA | 766 | Q9Y5H3 | |
| NAPYITAPSNTSHKL | 711 | Q08174 | |
| DLARHYKSSSPLPTV | 991 | O60245 | |
| HKPRVNPVTSLSENY | 391 | Q14432 | |
| SPVVVEKSNSYPHQL | 31 | Q8IZD2 | |
| AALHPNKDAYRPTTD | 3231 | O94854 | |
| EDPQAVTYAPVKHSS | 536 | O75022 | |
| DSPDLARHYKSASPQ | 931 | Q9BZA7 | |
| ARHYKSASPQPAFQI | 936 | Q9BZA7 | |
| PSPIANTFLHYRTSK | 51 | Q3MIN7 | |
| KYRPSHSDKAANPEV | 691 | O94988 | |
| NPLYRKPISTHTVDF | 771 | P18084 | |
| YERRHSSSSKPPLAV | 166 | O15265 | |
| STKTHQESAEPKYLP | 311 | Q9BXL5 | |
| AFLRKDHQSTPPVQY | 441 | Q5TIA1 | |
| PPLFSQQHYKASVSE | 536 | Q6V1P9 | |
| VAHSPQGYNTAREKP | 261 | O00461 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5H0 | |
| ESAVHSQYKRSPNVP | 646 | Q99575 | |
| LNDSAKPYSAHDPLT | 196 | Q58A45 | |
| PSQRITAKTALAHPY | 271 | Q00526 | |
| YKAHQRQLTPPEGSS | 516 | Q99613 | |
| NVYIHPTAKVAPSAV | 286 | Q96IJ6 | |
| PTPRKFLDTSHYSTA | 236 | Q96A65 | |
| HRAPVSQAAKFDPST | 701 | Q01780 | |
| ASYTPSPARSTHLKT | 416 | Q96DF8 | |
| PTPAKSHYVFNLRDL | 2286 | Q9C0G6 | |
| SALSPNHRIYSSPIA | 661 | A0AVK6 | |
| SSHDSDPRYSDPQIK | 1221 | Q96N67 | |
| YRNLPDHSAATKPSL | 416 | P14384 | |
| AYKDNRAPSVTSATH | 216 | O95500 | |
| CEEVKQTPPYDSSHR | 426 | Q8IXL6 | |
| HDTSLKPISVSYNPA | 41 | P00915 | |
| TNHIQETAPKYTEPL | 1061 | Q5SYB0 | |
| PSTEYNQSHIKALLP | 401 | Q7Z7M9 | |
| CPSERVHISTPNKYE | 946 | Q8IZJ3 | |
| SSPITRICAQEYHPK | 101 | Q6B9Z1 | |
| PPSLYATRISKAHQE | 286 | Q9NSG2 | |
| HAKDPDAANSPIRYS | 406 | P55287 | |
| TPTKRLQYSQDIPSH | 356 | O60941 | |
| VPSNYITPVNSLEKH | 111 | P00519 | |
| RSVKNIHSTPAYPDA | 731 | Q8IXH8 | |
| SHQFSEPPKIRASYI | 566 | Q5JRC9 | |
| SYLSNSQTPERHKPE | 851 | Q7Z4H7 | |
| IPKRCSNTPEEHTAY | 201 | A6NC97 | |
| FSLKNTTRPYHSLPS | 181 | Q8NBI2 | |
| SPSVSLKQVEHYDPT | 406 | O14682 | |
| AHDPDSSNSPVRYSI | 401 | Q9ULB5 | |
| LYFPRSPSANEKSLH | 676 | O94868 | |
| QSSPPKDVESYIHRS | 511 | Q9NR30 | |
| NPHYSPETSAKTTIV | 3491 | Q9P225 | |
| LDKNTSRTIYDPVHA | 206 | P34925 | |
| SPTEEGQLRPKTYHT | 501 | Q66K64 | |
| TPSYFVTNEAPKRIH | 261 | Q9Y661 | |
| YNFPSSEPRAKHSVK | 281 | P15509 | |
| LPSASKEPDNHVYTR | 26 | P36268 | |
| DLARHYKSASPQPAF | 966 | Q9BZA8 | |
| AAVHLSKSRTDYQPT | 111 | Q86T96 | |
| ADSRKSHLIFPQPNY | 761 | Q9Y5H4 | |
| YERQSPTPVLHSAVA | 56 | Q13368 | |
| LQPPSTYAVKDHVAT | 261 | Q8NGR8 | |
| RNPSEEKLHYPNASS | 386 | Q9UPX6 | |
| ETAHTQPSPNDRSLY | 66 | A7E2F4 | |
| NPPQVATYHRAIKVT | 206 | Q13950 | |
| PKSTSSPVTTYHLQR | 2971 | Q5T011 | |
| SHRTPDAKYTQPDAA | 226 | P84550 | |
| KDSRTVTVSHRPQPY | 276 | Q8IUD6 | |
| DPVPANQTHRTKFIY | 681 | Q9UIG8 | |
| HPKNNYSSRTPCSSL | 356 | Q9NUQ6 | |
| KLSYIQPRTQETPSH | 81 | Q8N9U0 | |
| DPQAVTYAEVKHSRP | 556 | Q8NHL6 | |
| PKSQTTAHELRYQVP | 721 | Q13393 | |
| RSASSPKQHPSESVY | 206 | Q8NET5 | |
| PKQHPSESVYTALQR | 211 | Q8NET5 | |
| AFNVTHLEPTKNTPY | 271 | Q9NXP7 | |
| THTAVKIAPRYSAPV | 866 | Q99707 | |
| PAYSLNTTKDSQTPH | 866 | Q1XH10 | |
| ARHSLVPSYEAPAAA | 516 | Q14190 | |
| YQSVSSTPRDPDKEH | 746 | Q6ZUB1 | |
| SSQIHSKDPRYGASP | 276 | O60733 | |
| DTVIKHYQRPASAQP | 286 | Q9ULL5 | |
| ASLSFHKARPQYPQE | 566 | Q96PQ1 | |
| QSHPAAKTQTYRPLS | 136 | O94875 | |
| YRPLSKSHSDNSPNA | 146 | O94875 | |
| YPASDVNTEKPSIHS | 246 | Q96GD3 | |
| HRNPLKATAPVSFNY | 6 | Q5VW32 | |
| TATPRIAKAEQHNYP | 646 | Q8IYA6 | |
| VPNAAEKTTYNHPLA | 526 | Q2KHT3 | |
| CPHNSRIATDYTKEP | 2056 | O75443 | |
| AELSSPVPYTNAVHR | 281 | Q9UL52 | |
| SAKVYHSPISENPLQ | 751 | O60296 | |
| DSEVPAAYQTPKKSH | 1096 | Q7Z2Z1 | |
| NQVSAYPLPEHRSTA | 236 | Q12768 | |
| VVLPDAYSRDHSPKA | 351 | Q8N7X1 | |
| PHVTEAYRAPASAAA | 576 | P41226 | |
| PIQSRIPAYKAVSHL | 11 | Q8NBB2 | |
| VQAVRDHAFTLSPYP | 411 | Q8N3E9 | |
| EEPSAPYAHTRKSFS | 1666 | Q9HCF6 | |
| AQHYLSKTPESSAQP | 866 | Q8IZM8 | |
| NNYLTVPAHKLDSPT | 681 | P19634 | |
| HRTPDAKYTQPDAAN | 191 | Q2VWA4 | |
| ISHVVSFSSQDPKYP | 6 | Q6ZNB5 | |
| VRFHPASVLSQPQYK | 1001 | Q9H6S0 | |
| STKSPFIYSPIIAHN | 566 | Q96Q05 | |
| RNPSPDHTYKRNGES | 386 | Q15695 | |
| PYRCQHLEKPETTST | 716 | Q6ZMP0 | |
| HQTPDFTPTKYKERA | 606 | Q9H4I2 | |
| RTLPNNKHYSCPTSE | 716 | Q9UPU7 | |
| TRPSAANKNFPYHVR | 401 | Q8NBT3 | |
| VPSQRVSQIEHFYKP | 226 | Q8WXB4 | |
| KNNLYPHRTAFPSVA | 466 | Q9C0D4 | |
| LVPQAAAPKVYERSH | 121 | Q96M85 | |
| NEYSIPKHINPVAAS | 266 | P53350 | |
| LPSASKEPDNHVYTR | 26 | P19440 | |
| TLNATTPHYVRCIKP | 646 | Q9ULV0 | |
| ATTPHYVRCIKPNDE | 641 | Q9NQX4 | |
| KYRQHPDTVKFTSVP | 1471 | P20929 |